Completed NCT01114737
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including La Jolla ADHD Drug i A study involving a medication or substance. From 8 Years to 65 Years
Countries United States, Canada
Sponsor BioMarin Pharmaceutical
Condition ADHD Terminated NCT01122927
This study was terminated in the United States, in Bulgaria, in Croatia, .... It is testing aripiprazole for schizophrenia.
Multiple locations, including Dothan Bipolarity, Schizophrenia Drug From 10 Years to 17 Years
Countries United States, Bulgaria, Croatia, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Bipolarity, Schizophrenia Completed NCT01892384
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
In Austin Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Boehringer Ingelheim
Condition Schizophrenia Completed NCT00480571
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Tel Litwinsky Schizophrenia Drug From 18 Years to 65 Years
Countries Israel, Romania
Sponsor BioLineRx, Ltd.
Condition Schizophrenia Completed NCT05076370
This summary needs review. Please check the official study record and contact the research team for details.
In West Haven Addiction Drug From 18 Years to 70 Years
Countries United States
Sponsor Yale University
Condition Addiction Withdrawn NCT01124877
This study was withdrawn. It is testing flexible Doses Of Oral Ziprasidone for Bipolarity.
Location not clearly listed Bipolarity Drug From 10 Years to 17 Years
Countries
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Bipolarity Completed NCT03624322
This summary needs review. Please check the official study record and contact the research team for details.
In Melbourne Bipolarity Drug From 18 Years to 55 Years
Countries Australia
Sponsor Impel Pharmaceuticals
Condition Bipolarity Terminated NCT01900522
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Glendale Schizophrenia Drug Over 18 Years
Countries United States
Sponsor Takeda
Condition Schizophrenia Completed NCT03238326
This study is completed in the United States, in France, in Italy, .... It is testing Open-Label Flexible-dose Brexpiprazole for schizophrenia.
Multiple locations, including Dothan Schizophrenia Drug From 13 Years to 17 Years
Countries United States, France, Italy, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Withdrawn NCT05562973
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed PTSD Drug From 18 Years to 80 Years
Countries
Sponsor Johns Hopkins University
Condition PTSD Completed NCT02773576
This summary needs review. Please check the official study record and contact the research team for details.
In Garden Grove Schizophrenia Drug From 18 Years to 70 Years
Countries United States
Sponsor Braeburn Pharmaceuticals
Condition Schizophrenia Completed NCT04187560
This summary needs review. Please check the official study record and contact the research team for details.
In Cincinnati Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor LB Pharmaceuticals Inc.
Condition Schizophrenia